On target 2: updated guidance for image-guided radiotherapy

HA McNair, KN Franks, M van Herk - Clinical Oncology, 2022 - clinicaloncologyonline.net
On target: ensuring geometric accuracy in radiotherapy was published in 2008 and aimed to
provide guidelines for image-guided radiotherapy (IGRT)[1]. At the time of publication …

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives

MC Lo Greco, G Marletta, G Marano, A Fazio… - Medicina, 2023 - mdpi.com
At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically
localized form of the disease, with most of them presenting with low-or intermediate-risk …

Stereotactic body radiotherapy for prostate cancer

NR Parikh, AU Kishan - American Journal of Men's Health, 2020 - journals.sagepub.com
Prostate cancer remains the most common and second most deadly cancer diagnosed
amongst US men. External beam radiotherapy is a standard-of-care definitive treatment …

1.5 T MR-guided daily-adaptive SBRT for prostate cancer: preliminary report of toxicity and quality of life of the first 100 patients

F Alongi, M Rigo, V Figlia, L Nicosia, R Mazzola… - Journal of Personalized …, 2022 - mdpi.com
Purpose: The present study reports the preliminary outcomes in terms of adverse events and
quality of life in the first 100 patients treated with 1.5 T MR-guided daily-adaptive stereotactic …

Acute side-effects of different radiotherapy treatment schedules in early prostate cancer

P Reinikainen, M Kapanen, T Luukkaala… - Anticancer …, 2022 - ar.iiarjournals.org
Background: Optimal radiation therapy (RT) fractionation in early prostate cancer in elderly
patients is controversial. We compared acute toxicities of fractionation schedules: 78/2 Gy …

Comparison of physician-recorded toxicities and patient-reported outcomes of five different radiotherapy methods for prostate cancer

M Ito, K Sasamura, Y Takase, T Kotsuma… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: To compare five radiotherapy methods for prostate cancer. Patients and
Methods: During 2005-2018, the data of patients with non-metastatic prostate cancer were …

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate …

H Yamazaki, K Masui, G Suzuki, N Aibe, D Shimizu… - Scientific Reports, 2022 - nature.com
To compare gastrointestinal (GI) and genitourinary (GU) toxicities in patients with localized
prostate cancer treated with ultrahypofractionated radiotherapy (UHF) or brachytherapy [BT; …

[HTML][HTML] Zalecenia postępowania diagnostyczno-terapeutycznego w raku gruczołu krokowego—stanowisko Polskiego Towarzystwa Onkologii Klinicznej i Polskiego …

P Wysocki, P Chłosta, A Antoniewicz… - Onkologia w …, 2024 - journals.viamedica.pl
W przypadku wszystkich chorób rozpoznawanie i leczenie powinno się prowadzić z
uwzględnieniem wytycznych postępowania, które są oparte na wiarygodnych dowodach …

Ultrahypofractionated radiotherapy versus conventional to moderate hypofractionated radiotherapy for clinically localized prostate cancer

H Yamazaki, G Suzuki, N Aibe, D Shimizu, T Kimoto… - Cancers, 2021 - mdpi.com
Simple Summary Recently, shortening treatment time is becoming more important.
Ultrahypofractionated radiotherapy (UHF) for localized prostate cancer is a fascinating …

Stereotactic radiotherapy and androgen deprivation therapy for localized prostate cancer: a retrospective mono-institutional experience

A Magli, ML Bonù, F Tonetto, E Moretti, G De Giorgi… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Stereotactic radiotherapy (SRT) is an effective treatment for localized
prostate cancer. However, is it not clear whether the addition of androgen deprivation …